Dr. Graff is the founder of Innov8 Health Policy, where she helps biopharmaceutical companies and patient advocacy groups turn the confusion and complexity into actions so they can navigate, translate, and modernize drug payment policies, enabling faster patient access, clearer coverage pathways, and improving incentives for innovation.
With leadership roles spanning managed care pharmacy (Academy of Managed Care Pharmacy), pharmaceutical policy research think tank (National Pharmaceutical Council), and leading industry health economics and outcomes research teams (MedImmune, Pfizer), Dr. Graff brings a perspective that allows her to anticipate challenges from payers and industry with evidence-informed policies.
As senior director and head of professional affairs at AMCP, she led strategic initiatives and best practices in how managed care pharmacy evaluates, covers, and pays for medications and provides care to their members. During her decade-plus tenure at the National Pharmaceutical Council, a health policy research organization supported by the leading biopharmaceutical companies, she spearheaded policy research on evidence generation, formulary design, and innovative reimbursement models.
Dr. Graff’s approach combines deep technical expertise with practical implementation experience. Her 35+ peer-reviewed publications and active participation in US and international multi-stakeholder groups ensure that her strategies reflect the latest evidence and payment trends. Her industry experience means she understands what works in practice and the complexities of change management.
